Skip to main content
SearchLogin or Signup

Reviews of "SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline"

Reviewers: Samreen Zaidi | πŸ“—πŸ“—πŸ“—πŸ“—β—»οΈ β€’ Roger Dodd (American Red Cross) | πŸ“’πŸ“’πŸ“’β—»οΈβ—»οΈ

Published onDec 04, 2020
Reviews of "SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline"

To read the original manuscript, click the link above.

Summary of Reviews: This study cautiously asserts that the outcome of a seroprevalence study is impacted by the declining prevalence rate, which impacts the sensitivity. Reviewers suggest the conclusion is rational and largely justifiable but limited by the data they utilize.

Reviewer 1 (Samreen Zaidi) | πŸ“—πŸ“—πŸ“—πŸ“—β—»οΈ

Reviewer 2 (Roger Dodd) | πŸ“’πŸ“’πŸ“’ ◻️◻️

RR:C19 Strength of Evidence Scale Key

πŸ“• ◻️◻️◻️◻️ = Misleading

πŸ“™πŸ“™ ◻️◻️◻️ = Not Informative

πŸ“’πŸ“’πŸ“’ ◻️◻️ = Potentially Informative

πŸ“—πŸ“—πŸ“—πŸ“—β—»οΈ = Reliable

πŸ“˜πŸ“˜πŸ“˜πŸ“˜πŸ“˜ = Strong

To read the reviews, click the links below.

Comments
0
comment

No comments here